IP Library Granted Patent US 11,628,088
Granted Patent B2
US 11,628,088 · App. 14/569,616 · Granted Apr 18, 2023

Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection

Inventors: Taina Tjäder (Littoinen, FI); Sara Heinonen (Tampere, FI)
Assignee: Bayer OY
A61F6/144A61B8/0841A61B8/481A61M31/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,628,088
App. No.
14/569,616
Granted
Apr 18, 2023
Kind
B2
Abstract

The present invention relates to ultrasonically detectable intrauterine systems and to a method for enhancing ultrasound detection of these systems. An intrauterine system having an inert metal coating on at least part of the body of the intrauterine system or at least one inert metal clip, pin, ring or sleeve fixedly positioned on the body of the intrauterine system is described.

Claims (33)

1. An ultrasonically detectable intrauterine system (IUS) for long-term insertion into a uterine cavity comprising:

a vertical arm having an upper end and a lower end;

horizontal arms extending from the upper end of the vertical arm;

a hormone-containing capsule mounted on the vertical arm; and

an image enhancing structure adapted to improve ultrasound imaging of the IUS, wherein the image enhancing structure comprises an inert metal ring, wherein:

the inert metal ring is composed of silver and has a width of 0.2 mm to 1 mm;

the inert metal ring surrounds the upper end of the vertical arm and is at least partially embedded in the upper end of the vertical arm; and

the inert metal ring does not comprise an active ingredient.

2. The IUS of claim 1 , further comprising at least two locking structures to keep the hormone-containing capsule in correct position during insertion, use and removal of the IUS.

3. The IUS of claim 1 wherein:

the hormone-containing capsule is a hormone-elastomer capsule that regulates a release of levonorgestrel and

the inert metal ring comprises a double ring that surrounds the upper end of the vertical arm.

4. The IUS of claim 1 , wherein the inert metal ring comprises 0.5 mm thick wire.

5. The IUS of claim 1 , wherein the inert metal ring is disposed within a 0.25 mm deep channel formed in the upper end of the vertical arm.

6. A method to form an intrauterine system (IUS) with improved visibility within a uterine cavity in an ultrasound examination, the method comprising:

forming a vertical arm of the IUS with a medicated capsule mounted thereto;

forming a first portion of one of an upper end of the vertical arm, a lower end of the vertical arm, and an end of a horizontal arm extending from the upper end of the vertical arm; and

surrounding the upper end of the vertical arm with an inert metal ring, wherein the inert metal ring is composed of silver, does not comprise an active ingredient, has a width of 0.2 to 1 mm, and is at least partially embedded in the upper end of the vertical arm.

7. The method of claim 6 , further comprising forming at least two locking structures on the vertical arm to keep the medicated capsule in correct position during insertion, use and removal of the IUS.

8. The method of claim 6 , further comprising:

forming a channel in the upper end of the vertical arm, wherein the channel is 0.25 mm; and disposing the inert metal ring within the channel to partially embed the inert metal ring within the upper end of the vertical arm.

9. The method of claim 6 , further comprising:

surrounding the lower end of the vertical arm or the end of the horizontal arm with a second inert metal ring, wherein the second inert metal ring is composed of silver.

10. The method of claim 6 , wherein the medicated capsule is a hormone-elastomer capsule that regulates a release of levonorgestrel.

11. The IUS of claim 1 wherein the hormone-containing capsule is a hormone-elastomer capsule that regulates a release of levonorgestrel.

12. A method for improving the visualization of an intrauterine system within the uterine cavity in an ultrasound examination comprising

providing an IUS according to claim 1 , and

inserting the IUS into the uterine cavity and examining the position of the IUS within the uterine cavity in an ultrasound examination.

13. The IUS of claim 1 , wherein the inert metal ring is composed of a silver wire.

14. The IUS of claim 1 comprising only one inert metal ring.

15. The method of claim 6 comprising only one inert metal ring.

16. The IUS of claim 1 , wherein the IUS is a hormonal device only, wherein the hormone-containing capsule comprises the only active hormonal ingredient.

17. The method of claim 6 , wherein the IUS is a hormonal device only, wherein the hormone-containing capsule comprises the only active hormonal ingredient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2019
From: TJAEDER, TAINA; HEINONEN, SARA
To: BAYER SCHERING PHARMA OY
Reel/Frame 049422/0442 →
CHANGE OF NAME Recorded Jun 10, 2019
From: BAYER SCHERING PHARMA OY
To: BAYER OY
Reel/Frame 049422/0614 →
Priority Claims (1)
FI 200550345 · Apr 5, 2005 · national
Continuity (2)
Continuation 11887901
Related Publication 20150164684A1 · Jun 18, 2015